The Molecular Basis for Recognition of CD1d/α-Galactosylceramide by a Human Non-Vα24 T Cell Receptor

PLoS Biology

Volumn 10, Issue 10, 2012, Pages

  López Sagaseta, Jacinto ^a   Kung, Jennifer E ^a   Savage, Paul B ^b   Gumperz, Jenny ^c   Adams, Erin J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b Brigham Young University   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; COMPLEMENTARITY DETERMINING REGION 1ALPHA; COMPLEMENTARITY DETERMINING REGION 2ALPHA; COMPLEMENTARITY DETERMINING REGION 3ALPHA; GALACTOSE; GLYCOLIPID; RECEPTOR PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL LINEAGE; CELL SPECIFICITY; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CRYSTALLOGRAPHY; HUMAN; HUMAN CELL; HYDROGEN BOND; LIGAND BINDING; LYMPHOCYTE SUBPOPULATION; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; MUTAGENESIS; NATURAL KILLER T CELL; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGENS, CD1D; BETA 2-MICROGLOBULIN; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; GALACTOSYLCERAMIDES; HUMANS; MOLECULAR SEQUENCE DATA; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL;

EID: 84868135044     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1001412     Document Type: Article

References (35)

1. Bendelac A, Savage PB, Teyton L, (2007) The biology of NKT cells. Annu Rev Immunol 25: 297-336.
2. Brigl M, Brenner MB, (2004) CD1: antigen presentation and T cell function. Annu Rev Immunol 22: 817-890.
3. Godfrey DI, Rossjohn J, (2011) New ways to turn on NKT cells. J Exp Med 208: 1121-1125.
4. Joyce S, Girardi E, Zajonc DM, (2011) NKT cell ligand recognition logic: molecular basis for a synaptic duet and transmission of inflammatory effectors. J Immunol 187: 1081-1089.
5. Kovalovsky D, Uche OU, Eladad S, Hobbs RM, Yi W, et al. (2008) The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat Immunol 9: 1055-1064.
6. Savage AK, Constantinides MG, Han J, Picard D, Martin E, et al. (2008) The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29: 391-403.
7. Kobayashi E, Motoki K, Uchida T, Fukushima H, Koezuka Y, (1995) KRN7000, a novel immunomodulator, and its antitumor activities. Oncol Res 7: 529-534.
8. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L, (2004) NKT cells: what's in a name? Nat Rev Immunol 4: 231-237.
9. Patel O, Pellicci DG, Gras S, Sandoval-Romero ML, Uldrich AP, et al. (2012) Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor. Nat Immunol 13: 857-863.
10. Girardi E, Maricic I, Wang J, Mac TT, Iyer P, et al. (2012) Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens. Nat Immunol 13: 851-856.
11. Uldrich AP, Patel O, Cameron G, Pellicci DG, Day EB, et al. (2011) A semi-invariant Valpha10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties. Nat Immunol 12: 616-623.
12. Brigl M, van den Elzen P, Chen X, Meyers JH, Wu D, et al. (2006) Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors. J Immunol 176: 3625-3634.
13. Gadola SD, Dulphy N, Salio M, Cerundolo V, (2002) Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes. J Immunol 168: 5514-5520.
14. Constantinides MG, Picard D, Savage AK, Bendelac A, (2011) A naive-like population of human CD1d-restricted T cells expressing intermediate levels of promyelocytic leukemia zinc finger. J Immunol 187: 309-315.
15. Godfrey DI, Pellicci DG, Patel O, Kjer-Nielsen L, McCluskey J, et al. (2010) Antigen recognition by CD1d-restricted NKT T cell receptors. Semin Immunol 22: 61-67.
16. Borg NA, Wun KS, Kjer-Nielsen L, Wilce MC, Pellicci DG, et al. (2007) CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448: 44-49.
17. Wun KS, Borg NA, Kjer-Nielsen L, Beddoe T, Koh R, et al. (2008) A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR. J Exp Med 205: 939-949.
18. Patel O, Pellicci DG, Uldrich AP, Sullivan LC, Bhati M, et al. (2011) Vbeta2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen. Proc Natl Acad Sci U S A 108: 19007-19012.
19. Pellicci DG, Patel O, Kjer-Nielsen L, Pang SS, Sullivan LC, et al. (2009) Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors. Immunity 31: 47-59.
20. Florence WC, Xia C, Gordy LE, Chen W, Zhang Y, et al. (2009) Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands. EMBO J 28: 3781.
21. Li Y, Girardi E, Wang J, Yu ED, Painter GF, et al. (2010) The Valpha14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode. J Exp Med 207: 2383-2393.
22. Mallevaey T, Clarke AJ, Scott-Browne JP, Young MH, Roisman LC, et al. (2011) A molecular basis for NKT cell recognition of CD1d-self-antigen. Immunity 34: 315-326.
23. Pellicci DG, Clarke AJ, Patel O, Mallevaey T, Beddoe T, et al. (2011) Recognition of beta-linked self glycolipids mediated by natural killer T cell antigen receptors. Nat Immunol 12: 827-833.
24. Yu ED, Girardi E, Wang J, Zajonc DM, (2011) Cutting edge: structural basis for the recognition of β-linked glycolipid antigens by invariant NKT cells. J Immunol 187: 2079-2083.
25. Lopez-Sagaseta J, Sibener LV, Kung JE, Gumperz J, Adams EJ, (2012) Lysophospholipid presentation by CD1d and recognition by a human Natural Killer T-cell receptor. The EMBO Journal 31: 2047-2059.
26. Matulis G, Sanderson JP, Lissin NM, Asparuhova MB, Bommineni GR, et al. (2010) Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop. PLoS Biol 8: e1000402 doi:10.1371/journal.pbio.1000402.
27. Mallevaey T, Scott-Browne JP, Matsuda JL, Young MH, Pellicci DG, et al. (2009) T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoire. Immunity 31: 60-71.
28. Gadola SD, Koch M, Marles-Wright J, Lissin NM, Shepherd D, et al. (2006) Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors. J Exp Med 203: 699-710.
29. Adams EJ, Luoma AM, (2012) The yin and yang of CD1d recognition. Nat Immunol 13: 814-815.
30. Otwinowski Z, Minor W, (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276: 307-326.
31. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, et al. (2007) Phaser crystallographic software. J Appl Crystallogr 40: 658-674.
32. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, et al. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66: 213-221.
33. Emsley P, Cowtan K, (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126-2132.
34. Collaborative Computational Project N (1994) The CCP4 Suite: programs for protein crystallography. Acta Cryst D50: 760-763.
35. Wun KS, Cameron G, Patel O, Pang SS, Pellicci DG, et al. (2011) A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells. Immunity 34: 327-339.